Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal smooth muscle motility and mechanosensitive neural elements refers to the integrated physiological system governing the movement of the digestive tract and its ability to sense physical stimuli. This system is composed of three primary components: the smooth muscle layers that execute contraction, the Interstitial Cells of Cajal (ICC) that function as electrical pacemakers, and the enteric nervous system (ENS) which provides local neural control (Sanders et al., 2014; Furness et al., 2013). Mechanosensitive neural elements, such as Intrinsic Primary Afferent Neurons (IPANs) and specialized ion channels like Piezo2, detect mechanical forces like stretch and tension to trigger the peristaltic reflex (Wang et al., 2017; Beyder & Farrugia, 2016). Dysfunction within this system leads to a variety of motility disorders, including gastroparesis, chronic idiopathic constipation, and irritable bowel syndrome (IBS), often characterized by either delayed transit or visceral hypersensitivity. Therapeutic strategies targeting this system typically involve modulating specific receptors or channels to either stimulate motility (prokinetics) or reduce pain and slow transit (antidiarrheals). Common pharmacological targets within this framework include 5-HT4 receptors, 5-HT3 receptors, and guanylate cyclase-C, which influence the signaling between neural elements and smooth muscle (Gershon, 2013).
Modulation of enteric neurotransmission via 5-HT4 receptor agonism, 5-HT3 receptor antagonism, D2 receptor antagonism, and activation of secretagogues like guanylate cyclase-C to influence smooth muscle contraction and fluid dynamics.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal smooth muscle motility and mechanosensitive neural elements.